Watson Pharmaceuticals (NYSE:WPI) crossed under its 10-day moving average of $60.95 on a volume of 319K shares. Swing traders may find an opportunity for a short position, as such a crossover often suggests lower prices in the near term.Watson Pharmaceuticals share prices have moved between a 52-week high of $73.35 and a 52-week low of $50.47 and are now trading 20% above that low price at $60.43 per share. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.4%.Potential upside of 26.6% exists for Watson Pharmaceuticals, based on a current level of $60.43 and analysts' average consensus price target of $76.53. The stock should find initial resistance at its 200-day moving average (MA) of $64.19 and further resistance at its 50-day MA of $64.71.Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company's core focus is specialty products, nephrology, urology, and generic products.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment